You may be eligible for
Instant Savings Program benefits if you:
Have been prescribed
INVEGA SUSTENNA® /
Currently have commercial insurance that covers medication costs for
This offer may not be combined with any other coupon, discount, prescription savings card, free trial, or other offer.
This program is not available to individuals enrolled in federal or state subsidized healthcare programs that cover prescription drugs, including Medicare, such as Medicare Part D
prescription drug benefit, Medicaid, TRICARE, or any other federal or state healthcare plan, including pharmaceutical assistance programs. Participants certify that they will not seek
reimbursement or compensation from any of these programs, to include a Flexible Spending Account (FSA), a Health Savings Account (HSA), or a Health Reimbursement Account (HRA).
The selling, purchasing, trading, or counterfeiting of this card is prohibited.
Offer good only in the United States and Puerto Rico. Janssen Pharmaceuticals, Inc., reserves the right to rescind, revoke, or amend this offer without notice at any time. Void
where prohibited, taxed, or otherwise restricted by law. For Massachusetts residents only, this offer is subject to change per state legislation.
Offer expires December 31, 2017. Each patient can enroll in this program only once per year.
INVEGA TRINZA® (3-month paliperidone palmitate) is a prescription medicine given by injection every 3 months
by a healthcare professional and used to treat schizophrenia. INVEGA TRINZA® is used in people who have
been treated with INVEGA SUSTENNA® (1-month paliperidone palmitate) for at least 4 months.
(In-VEY-guh Suss-TEN-uh) (paliperidone palmitate) Extended-Release Injectable
Suspension is a prescription medicine given by injection by a healthcare professional. INVEGA SUSTENNA®
is used to treat schizophrenia.
IMPORTANT SAFETY INFORMATION
Do not receive INVEGA TRINZA® or INVEGA SUSTENNA® if you
are allergic to paliperidone, paliperidone palmitate, risperidone, or any of the ingredients in INVEGA TRINZA® or INVEGA SUSTENNA®. See end of the Patient Information leaflet in the full Prescribing Information for a complete list of INVEGA TRINZA® and INVEGA SUSTENNA® ingredients.
Patients (particularly the elderly) taking antipsychotics with certain health conditions or those on long-term therapy
should be evaluated by their healthcare provider for the potential risk of falls.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter
medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show to your
healthcare provider or pharmacist when you get a new medicine.
What should I avoid while receiving INVEGA TRINZA® and INVEGA SUSTENNA®?
INVEGA TRINZA® and INVEGA SUSTENNA® may cause serious side effects, including:
The most common side effects of INVEGA TRINZA® include:
injection site reactions, weight gain, headache, upper respiratory tract infections, feeling restlessness or difficulty sitting still, slow movements, tremors, stiffness and shuffling walk.
The most common side effects of INVEGA SUSTENNA® include:
injection site reactions; sleepiness or
drowsiness; dizziness; feeling of inner restlessness or needing to be constantly moving; abnormal muscle
movements, including tremor (shaking), shuffling, uncontrolled involuntary movements, and abnormal movements
of your eyes.
Tell your healthcare provider if you have any side effect that bothers you or does not go away. These are not all
the possible side effects of INVEGA TRINZA® or INVEGA SUSTENNA®. For more information, ask your healthcare provider or
Call your doctor for medical advice about side effects. You may report side effects of prescription drugs to the FDA at 1-800-FDA-1088.
General information about the safe and effective use of INVEGA TRINZA®.
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not
use INVEGA TRINZA® for a condition for which it was not prescribed. Do not give INVEGA TRINZA® to other
people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or
healthcare provider for information about INVEGA TRINZA® that is written for health providers.
This Patient Information leaflet summarizes the most important information about INVEGA TRINZA®. If you
would like more information, talk with your healthcare provider.
You can ask your healthcare provider or pharmacist for more information that is written for healthcare
providers. For more information, go to www.invegatrinzahcp.com or call 1-800-526-7736.
Please see full Prescribing Information including Boxed WARNING for INVEGA TRINZA®.
Please see full Prescribing Information including Boxed WARNING for INVEGA SUSTENNA®.
RISPERDAL CONSTA® (risperidone) is used for the treatment of schizophrenia and for the longer-term treatment of Bipolar I Disorder.
IMPORTANT SAFETY INFORMATION FOR RISPERDAL CONSTA®
Do not receive RISPERDAL CONSTA® if you are allergic to paliperidone, risperidone, or any of
the ingredients in RISPERDAL CONSTA®.
Neuroleptic Malignant Syndrome (NMS) is a rare and potentially fatal side effect reported with
RISPERDAL CONSTA® and similar medicines. Call your doctor immediately if the person
being treated develops symptoms such as high fever; stiff muscles; shaking; confusion;
sweating; changes in pulse, heart rate, or blood pressure; or muscle pain and weakness.
Treatment should be stopped if the person being treated has NMS.
Tardive Dyskinesia (TD) is a serious, sometimes permanent side effect reported with
RISPERDAL CONSTA® and similar medications. TD includes uncontrollable movements of the
face, tongue, and other parts of the body. The risk of developing TD and the chance that it will
become permanent is thought to increase with the length of therapy and the overall dose
taken by the patient. This condition can develop after a brief period of therapy at low doses,
although this is much less common. There is no known treatment for TD, but it may go away
partially or completely if therapy is stopped.
Atypical antipsychotic drugs have been associated with metabolic changes that can
increase cardiovascular/cerebrovascular risks. These changes may include:
RISPERDAL CONSTA® and similar medications can raise the blood levels of a hormone
known as prolactin, causing a condition known as hyperprolactinemia. Blood levels of prolactin
remain elevated with continued use. Some side effects seen with these medications include
the absence of a menstrual period; breasts producing milk; the development of breasts by
males; and the inability to achieve an erection.
Some people taking RISPERDAL CONSTA® may feel faint or lightheaded when they stand up
or sit up too quickly. By standing up or sitting up slowly and following your healthcare
professionalʼs dosing instructions, this side effect can be reduced or it may go away over
Patients (particularly the elderly) taking antipsychotics with certain health conditions or those on long-term
therapy should be evaluated by their healthcare professional for the potential risk of falls.
Blood problems such as low numbers of white blood cells have been reported in patients
taking risperidone and similar medications. In some cases it has been serious and life-threatening.
Depending upon your medical condition, your doctor may choose to test your
blood as you start therapy with RISPERDAL CONSTA®.
RISPERDAL CONSTA® may affect your alertness or driving ability; therefore, do not drive or
operate machinery before talking to your healthcare professional.
RISPERDAL CONSTA® should be used cautiously in people with a seizure disorder, who have
had seizures in the past, or who have conditions that increase their risk for seizures.
Painful, long lasting erections have been reported with the use of RISPERDAL CONSTA®. Call
your doctor immediately if you think you are having this problem.
Extrapyramidal Symptoms (EPS) are usually persistent movement disorders or muscle
disturbances, such as restlessness, tremors, and muscle stiffness. If you observe any of these
symptoms, talk to your healthcare professional.
Inform your healthcare professional if you become pregnant or intend to become pregnant
during therapy with RISPERDAL CONSTA®. Caution should be used when administering
RISPERDAL CONSTA® to a nursing woman.
RISPERDAL CONSTA® may make you more sensitive to heat. You may have trouble cooling
off, or be more likely to become dehydrated, so take care when exercising or when doing
things that make you warm.
Some medications interact with RISPERDAL CONSTA®. Please inform your healthcare
professional of any medications or supplements that you are taking. Avoid alcohol while taking RISPERDAL CONSTA®.
In studies of people taking RISPERDAL CONSTA®, the most common side effects in the
treatment of schizophrenia were headache, slow movements (including tremor [shaking],
stiffness, and a shuffling walk), dizziness; feeling of inner restlessness or needing to be constantly moving; tiredness, constipation, indigestion,
sleepiness, weight gain, pain in the limbs, and dry mouth.
In studies of people taking RISPERDAL CONSTA®, the most common side effects in the
treatment of bipolar disorder were weight gain (when used alone) and slow movements
(including with tremor [shaking], stiffness, and a shuffling walk) and tremor (when used with
lithium or valproate).
This is not a complete list of all possible side effects. Ask your doctor or treatment team if you have
any questions or want more information.
If you have any questions about RISPERDAL CONSTA® or your therapy, talk with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please see full Prescribing Information including Boxed WARNING for RISPERDAL CONSTA®.